Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin/Ezetimibe vs High-Intensity Rosuvastatin in ASCVD
NCT04080310Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Mar 2018
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin, ezetimibe in atherosclerotic cardiovascular disease (ASCVD), sponsored by Seoul National University Bundang Hospital. Started Mar 2018; status: completed.
02
Drugs
rosuvastatinezetimibe
03
Conditions
atherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT04080310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04080310.